You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Lei Wang1, Li Li1, Zi-Han Zhou2
1State Key Laboratory of Natural Medicines, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Researchers identified novel small molecules targeting the Hsp90-Cdc37 protein-protein interaction (PPI). Compound 10 showed potent antiproliferative activity against cancer cells, representing a new class of Hsp90-Cdc37 PPI inhibitors.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: